Stifel Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $110
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
Stifel analyst Rick Wise maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $105 to $110.
Stifel analyst Rick Wise maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $105 to $110.